Genentech · 13 hours ago
2026 Summer Intern - Product Development Data Sciences
South San Francisco, CA
Internship
Hybrid
Intern
$50/hr - $50/hr
Start in 2026 SummerGenentech is a leading biotechnology company seeking a 2026 Summer Intern in Product Development Data Sciences. The intern will develop innovative methods and tools for clinical drug development and work on software tools/packages while collaborating with a talented team in the biotechnology industry.
BiotechnologyLife ScienceManufacturing
Responsibilities
Innovative study design: develop novel methods and tools for clinical drug development with potential applications in diverse therapeutic areas such as immunology, ophthalmology, neuroscience, and CVRM
Developing software tools/packages: Developing code for novel methods and run simulations
Qualification
Required
Must have attained a Master's Degree (no more than a year ago)
Must be pursuing a PhD (enrolled student)
Required Majors: Statistics, Biostatistics, Computer Science, Data Science, Mathematics, Biotechnology, or related fields
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Passion for learning and curious about drug development in the biotech industry
Solid training in statistics, machine learning, and/or data science
Strong programming ability in R/Python
Preferred
Familiarity with longitudinal data is a plus
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
2026-01-23
Genetic Engineering News
2026-01-23
Company data provided by crunchbase